Propanc Biopharma Inc (PPCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Operating Expenses | 599 | 502 | 404 | 486 | 727 |
| Operating Income | -599 | -502 | -404 | -486 | -727 |
| Interest Expense | 114 | 167 | 178 | 110 | 29 |
| Other Income | -192 | 207 | -274 | 105 | -24 |
| Pre-tax Income | -905 | -463 | -855 | -491 | -780 |
| Income Tax | 0 | 0 | -56 | N/A | -1 |
| Net Income Continuous | -905 | -463 | -800 | -491 | -779 |
| Net Income | $-905 | $-463 | $-800 | $-491 | $-779 |
| EPS Basic Total Ops | -49.18 | -0.01 | -0.02 | -0.02 | 0.48 |
| EPS Basic Continuous Ops | -38.92 | -0.01 | -0.02 | -0.02 | 0.61 |
| EPS Diluted Total Ops | -49.18 | -0.01 | -0.02 | -0.02 | 0.48 |
| EPS Diluted Continuous Ops | -38.92 | -0.01 | -0.02 | -0.02 | 0.61 |
| EBITDA(a) | $-599 | $-502 | $-403 | $-486 | $-726 |